Dachun Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dachun Yao has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Yulan Gou
Department of Neurology, Wuhan No.1 Hospital, 215 Zhongshan Rd. Wuhan 430022, China
3 shared publicationsZhaoyu Liu
Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430030, China
3 shared publicationsHaimou Zhang
School of Life Sciences, Hubei University, Wuhan 430062, PR China
2 shared publicationsHuawen Li
School of Public Health, Guangdong Medical College, Dongguan 523808, China
2 shared publications- Zheng-Xiang Liu
Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
2 shared publications Athanasios G. Vlessidis
Laboratory of Analytical Chemistry, Department of Chemistry, University of Ioannina, Greece
1 shared publication
Latest Publications
- 1 July 2016
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 96, 223-233
ERβ expression in the endothelium ameliorates ischemia/reperfusion-mediated oxidative burst and vascular injury
- 1 July 2016
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 96, 223-233
ERβ expression in the endothelium ameliorates ischemia/reperfusion-mediated oxidative burst and vascular injury
- 1 October 2015
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 87, 92-101
Estradiol mediates vasculoprotection via ERRα-dependent regulation of lipid and ROS metabolism in the endothelium
- 1 October 2015
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 87, 92-101
Estradiol mediates vasculoprotection via ERRα-dependent regulation of lipid and ROS metabolism in the endothelium
- Open Access
- 1 January 2014
- Published by Elsevier in Redox Biology
- Vol. 3, 88-99
Estradiol improves cardiovascular function through up-regulation of SOD2 on vascular wall
- 1 January 2014
- Published by Elsevier in Redox Biology
- Vol. 3, 88-99
Open AccessEstradiol improves cardiovascular function through up-regulation of SOD2 on vascular wall
- Open Access
- 23 March 2009
- Published by Wiley in The FEBS Journal
- Vol. 276 (9) , 2599-2614
Betulinic acid‐mediated inhibitory effect on hepatitis B virus by suppression of manganese superoxide dismutase expression
The betulinic acid (BetA) purified from Pulsatilla chinensis (PC) has been found to have selective inhibitory effects on hepatitis B virus (HBV). In hepatocytes from HBV‐transgenic mice, we showed that BetA substantially inhibited HBV replication by downregulation of manganese superoxide dismutase (SOD2) expression, with subsequent reactive oxygen species generation and mitochondrial dysfunction. Also, the HBV X protein (HBx) is suppressed and translocated into the mitochondria followed by cytochrome c release. Further investigation revealed that SOD2 expression was suppressed by BetA‐induced cAMP‐response element‐binding protein dephosphorylation at Ser133, which subsequently prevented SOD2 transcription through the cAMP‐response element‐binding protein‐binding motif on the SOD2 promoter. SOD2 overexpression abolished the inhibitory effect of BetA on HBV replication, whereas SOD2 knockdown mimicked this effect, indicating that BetA‐mediated HBV clearance was due to modulation of the mitochondrial redox balance. This observation was further confirmed in HBV‐transgenic mice, where both BetA and PC crude extracts suppressed SOD2 expression, with enhanced reactive oxygen species generation in liver tissues followed by substantial HBV clearance. We conclude that BetA from PC could be a good candidate for anti‐HBV drug development.
- 23 March 2009
- Published by Wiley in The FEBS Journal
- Vol. 276 (9) , 2599-2614
Open AccessBetulinic acid‐mediated inhibitory effect on hepatitis B virus by suppression of manganese superoxide dismutase expression
The betulinic acid (BetA) purified from Pulsatilla chinensis (PC) has been found to have selective inhibitory effects on hepatitis B virus (HBV). In hepatocytes from HBV‐transgenic mice, we showed that BetA substantially inhibited HBV replication by downregulation of manganese superoxide dismutase (SOD2) expression, with subsequent reactive oxygen species generation and mitochondrial dysfunction. Also, the HBV X protein (HBx) is suppressed and translocated into the mitochondria followed by cytochrome c release. Further investigation revealed that SOD2 expression was suppressed by BetA‐induced cAMP‐response element‐binding protein dephosphorylation at Ser133, which subsequently prevented SOD2 transcription through the cAMP‐response element‐binding protein‐binding motif on the SOD2 promoter. SOD2 overexpression abolished the inhibitory effect of BetA on HBV replication, whereas SOD2 knockdown mimicked this effect, indicating that BetA‐mediated HBV clearance was due to modulation of the mitochondrial redox balance. This observation was further confirmed in HBV‐transgenic mice, where both BetA and PC crude extracts suppressed SOD2 expression, with enhanced reactive oxygen species generation in liver tissues followed by substantial HBV clearance. We conclude that BetA from PC could be a good candidate for anti‐HBV drug development.